Atlantic International

SeqLL Inc. specializes in providing highly accurate RNA and DNA sequencing services using its proprietary True Single Molecule Sequencing (tSMS) technology. Unlike traditional sequencing methods that require amplification and can distort transcript counts, tSMS offers precise quantification by eliminating this step. The company serves academic researchers, pharmaceutical companies, and clinical laboratories, primarily in the genomics and biotechnology sectors. SeqLL's business model includes offering sequencing services, selling sequencing equipment, and providing bioinformatics support. Revenue is generated through service contracts, equipment sales, and ongoing customer support agreements. The company is committed to enabling research breakthroughs by delivering unparalleled accuracy and customer service.

Keywords: RNA sequencing, DNA sequencing, tSMS technology, genomics, biotechnology, bioinformatics, academic research, pharmaceutical, clinical laboratories, precision quantification.